Suppr超能文献

C3-杂芳酰基大麻素作为 CB2 大麻素受体的光标记配体。

C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.

机构信息

Department of Chemistry, University of Hawaii at Manoa, 2545 The Mall, Honolulu, HI 96822, USA.

出版信息

Bioorg Med Chem Lett. 2012 Aug 15;22(16):5322-5. doi: 10.1016/j.bmcl.2012.06.013. Epub 2012 Jun 15.

Abstract

A series of tricyclic cannabinoids incorporating a heteroaroyl group at C3 were prepared as probes to explore the binding site(s) of the CB1 and CB2 receptors. This relatively unexplored structural motif is shown to be CB2 selective with K(i) values at low nanomolar concentrations when the heteroaromatic group is 3-benzothiophenyl (41) or 3-indolyl (50). When photoactivated, the lead compound 41 was shown to successfully label the CB2 receptor through covalent attachment at the active site while 50 failed to label. The benzothiophenone moiety may be a photoactivatable moiety suitable for selective labeling.

摘要

一系列在 C3 位上引入杂芳酰基的三环大麻素被制备为探针,以探索 CB1 和 CB2 受体的结合部位。当杂芳基为 3-苯并噻吩基(41)或 3-吲哚基(50)时,该相对未探索的结构基序显示出对 CB2 的选择性,其 K(i) 值在低纳摩尔浓度下。当被光激活时,先导化合物 41 被证明能够通过在活性部位的共价结合成功标记 CB2 受体,而 50 则未能标记。苯并噻吩酮部分可能是适合选择性标记的光活化部分。

相似文献

1
C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5322-5. doi: 10.1016/j.bmcl.2012.06.013. Epub 2012 Jun 15.
2
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Curr Med Chem. 2008;15(14):1428-43. doi: 10.2174/092986708784567716.
3
Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.
Chemistry. 2020 Jan 27;26(6):1380-1387. doi: 10.1002/chem.201904584. Epub 2020 Jan 21.
5
CB1 and CB2 cannabinoid receptor binding studies based on modeling and mutagenesis approaches.
Mini Rev Med Chem. 2005 Jul;5(7):651-8. doi: 10.2174/1389557054368754.
6
7
Preface.
Methods Enzymol. 2017;593:xvii-xxiv. doi: 10.1016/S0076-6879(17)30257-4.
10
3'-functionalized adamantyl cannabinoid receptor probes.
J Med Chem. 2015 Apr 9;58(7):3104-16. doi: 10.1021/jm501960u. Epub 2015 Mar 20.

引用本文的文献

1
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
Pharmacol Rev. 2023 Sep;75(5):885-958. doi: 10.1124/pharmrev.122.000600. Epub 2023 May 10.
2
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.
RSC Med Chem. 2022 Apr 4;13(5):497-510. doi: 10.1039/d2md00006g. eCollection 2022 May 25.
3
Druggable Lipid Binding Sites in Pentameric Ligand-Gated Ion Channels and Transient Receptor Potential Channels.
Front Physiol. 2022 Jan 4;12:798102. doi: 10.3389/fphys.2021.798102. eCollection 2021.
4
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes.
ChemMedChem. 2020 Aug 5;15(15):1374-1389. doi: 10.1002/cmdc.202000298. Epub 2020 Jun 24.
5
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB Receptor Expression and Ligand Engagement in Human Cells.
J Am Chem Soc. 2018 May 16;140(19):6067-6075. doi: 10.1021/jacs.7b11281. Epub 2018 Feb 16.
6
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.
Bioorg Med Chem. 2017 Dec 15;25(24):6427-6434. doi: 10.1016/j.bmc.2017.10.015. Epub 2017 Oct 16.
8
Synthesis and Properties of Fully-Conjugated Indacenedithiophenes.
Chem Sci. 2014 Mar 1;5(3):1008-1014. doi: 10.1039/C3SC53181C.
9
2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.
J Med Chem. 2014 May 22;57(10):3891-911. doi: 10.1021/jm500220s. Epub 2014 May 1.
10
Novel adamantyl cannabinoids as CB1 receptor probes.
J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14.

本文引用的文献

2
Heteroadamantyl cannabinoids.
J Med Chem. 2010 Aug 12;53(15):5656-66. doi: 10.1021/jm100390h.
4
Oxaza adamantyl cannabinoids. A new class of cannabinoid receptor probes.
J Org Chem. 2006 Sep 29;71(20):7800-4. doi: 10.1021/jo061352c.
5
Structural requirements for cannabinoid receptor probes.
Handb Exp Pharmacol. 2005(168):209-46. doi: 10.1007/3-540-26573-2_7.
6
Plant, synthetic, and endogenous cannabinoids in medicine.
Annu Rev Med. 2006;57:553-74. doi: 10.1146/annurev.med.57.011205.135648.
7
Cannabinoid pharmacology: the first 66 years.
Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S163-71. doi: 10.1038/sj.bjp.0706406.
10
Adamantyl cannabinoids: a novel class of cannabinergic ligands.
J Med Chem. 2005 Jul 14;48(14):4576-85. doi: 10.1021/jm058175c.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验